60 DEGREES PHARMACEUTICALS INC C/WTS 12/07/2028 (TO PUR COM)(SXTPW.US)

Last Updated 19:00:00 ET
longbridge loading

60 Degrees Pharmaceuticals 1Q 2026: Revenue $162.09K, EPS ($1.28) — 10-Q Summary

TradingView·
US
SXTPW
+0.75%
US
SXTP
-2.08%
US
GDRX
+0.80%
TradingView·
US
SXTPW
+0.75%
US
SXTP
-2.08%
US
GDRX
+0.80%

60 DEGREES PHARMACEUTICALS INC C/WTS 12/07/2028 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 162.09 K

Earnings Watch·
US
SXTPW
+0.75%
Earnings Watch·
US
SXTPW
+0.75%

60 Degrees Pharmaceuticals shares are trading higher. The company reported its Q4 financial results.

benzinga_article·
US
BIB
+0.05%
US
SXTPW
+0.75%
US
LABU
-2.35%
benzinga_article·
US
BIB
+0.05%
US
SXTPW
+0.75%
US
LABU
-2.35%

60 Degrees Pharmaceuticals Announces 2025 Annual Results | SXTP Stock News

StockTitan·
US
SXTPW
+0.75%
US
XBI
-0.69%
US
VHT
+0.97%
StockTitan·
US
SXTPW
+0.75%
US
XBI
-0.69%
US
VHT
+0.97%

60 DEGREES PHARMACEUTICALS INC C/WTS 12/07/2028 (TO PUR COM) | 10-K: FY2025 Revenue: USD 1.005 M

Earnings Watch·
US
SXTPW
+0.75%
Earnings Watch·
US
SXTPW
+0.75%

60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract | SXTP Stock News

StockTitan·
US
BIB
+0.05%
US
SXTPW
+0.75%
US
IXJ
+0.79%
StockTitan·
US
BIB
+0.05%
US
SXTPW
+0.75%
US
IXJ
+0.79%

60 Degrees Pharmaceuticals files updated legal opinion confirming ATM program share validity

TradingView·
US
VHT
+0.97%
US
BIB
+0.05%
US
ARKG
+0.04%
TradingView·
US
VHT
+0.97%
US
BIB
+0.05%
US
ARKG
+0.04%
© 2026 Longbridge｜Disclaimer